Physician profile
Saritha Gorantla
NPI 1538416318
$3,250.09
in general payments reported to CMS, 2019-2025
18 companies · $278 in 2025
The $278 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,129 · 2020: $267 · 2021: $137 · 2022: $389 · 2023: $475 · 2024: $576 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,252 · Education: $76.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,251.69 |
| Education | $76.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,091.03 | 2019-2023 | |
| Janssen Biotech, INC. | $619.62 | 2019-2025 | Tremfya |
| Lilly USA, LLC | $248.53 | 2024 | Omvoh |
| Gilead Sciences, INC. | $243.79 | 2019-2025 | Livdelzi |
| E.R. Squibb & Sons, L.L.C. | $185.42 | 2023 | Zeposia |
| Ardelyx, INC. | $125.00 | 2024 | Ibsrela |
| Janssen Scientific Affairs, LLC | $124.81 | 2019 | |
| Medtronic, INC. | $123.56 | 2024 | Interstim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $119.30 | 2020 | |
| Genzyme Corporation | $99.98 | 2022 | |
| Phathom Pharmaceuticals, INC. | $78.82 | 2024 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $57.68 | 2019 | |
| Shire North American Group INC | $39.29 | 2019 | |
| Csl Behring | $27.72 | 2019 | |
| Janssen Pharmaceuticals, INC | $23.38 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.87 | 2019 | |
| Braintree Laboratories, INC. | $14.80 | 2019 | |
| Qol Medical, LLC | $12.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saritha Gorantla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.